Mobia Medical, Inc. (MOBI) Stock Analysis
A live, multi-source view of Mobia Medical, Inc. (MOBI): real-time price, technical indicators, Wall Street analyst consensus, recent news sentiment and social buzz — aggregated into one place so you can size up the stock at a glance.
About Mobia Medical, Inc.
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.
Sector: Healthcare · Industry: Medical Devices · United States · 167 employees · mobia.com
Key statistics · as of 2026-09-06
As of 2026-09-06, Mobia Medical, Inc. (MOBI) had a market capitalization of $387.2M (forward -5.3); the shares traded in a 52-week range of $10.19 – $15.29 (-1.0% over the year).
- Market cap
- $387.2M
- Enterprise value
- $218.5M
- Forward P/E
- -5.3
- Price / book
- 2.24
- EPS (trailing)
- $-1.93
- EPS (forward)
- $-2.20
- Payout ratio
- 0.0%
- 52-week range
- $10.19 – $15.29
- 52-week change
- -1.0%
- Average volume
- 150,406
- Shares outstanding
- 33.3M
- Short % of float
- 2.28%
- Profit margin
- -141.6%
Fundamental figures are recorded once every few days, dated above; they are not live and can differ from the interactive tiles.
Last universe scan · 2026-09-10
In RapidTradeView’s 2026-09-10 scan of the US universe, Mobia Medical, Inc. (MOBI) last closed at $10.82 (the last completed close before that scan).
Technicals at the scan: RSI 44 (neutral territory), price -4.4% versus its 20-day average, 20-day versus 50-day average spread -3.6%, MACD histogram 0.01.
Sentiment inputs: StockTwits 100% bullish; analyst consensus score 81/100.
Next scheduled company event: in 60 days from the scan date.
Scan values are recorded once per trading day and are not live quotes; the interactive tiles above update in real time.
Smart Money · last 90 days
Members of Congress disclosed 0 buys and 0 sells of MOBI; corporate insiders filed 5 buys and 0 sells (1 filer, latest disclosure 2026-08-20). Filings arrive days to weeks after the trade and are not a live signal. Most active filers: Casey M. Tansey (5B/0S). Who is trading what
RapidTradeView pick record
MOBI has not appeared in the daily picks yet. Full scoreboard
What this page covers
RapidTradeView pulls Mobia Medical, Inc. (MOBI) data from multiple independent sources and combines it into a single dashboard. Below the summary you’ll find live, interactive tiles for each of the following:
- Price & chart — real-time quote with pre/post-market moves and a line or candlestick chart.
- Technical indicators — RSI, MACD, moving averages, Bollinger Bands, volume and support/resistance, distilled into one overall signal.
- Analyst consensus — the buy/hold/sell breakdown and price targets published by Wall Street analysts.
- News sentiment — recent headlines, each scored for tone so the prevailing narrative is obvious.
- Earnings — current EPS, year-over-year change and the next scheduled earnings date.
- Social buzz — Reddit mention volume and StockTwits sentiment for the retail-trader angle.
How to read the signals
No single indicator tells the whole story. A bullish technical reading paired with a cautious analyst consensus, or strong social buzz against weak earnings, is exactly the kind of tension this view is built to surface. RapidTradeView’s signals are generated by deterministic, statistical models — they describe what the data is doing, they are not personalised recommendations to buy or sell MOBI.
Disclaimer: RapidTradeView is an educational sentiment-aggregation tool, not a licensed financial adviser, broker, or dealer. Nothing here is financial, investment, tax, or legal advice. Markets are risky and you can lose money. Always do your own research and consult a qualified professional before making any investment decision.